Andrew Anderson shares insights on the factors that may shape the next major advance in pharmaceutical informatics strategy.

Frost & Sullivan recognizes L7|ESP® for its unified platform architecture, workflow orchestration, and AI-ready design. AUSTIN, Texas, Oct. 29, 2025 /PRNewswire/ -- L7 Informatics, a leader in digital ...

PLANEGG, Germany--(BUSINESS WIRE)--Biomax Informatics AG announces that their longtime client, Boehringer Ingelheim, has signed a multi-year license for the BioXM™ Knowledge Management Environment to ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the drug discovery informatics market and it is poised to grow by USD 2.54 bn during 2020-2024, progressing at a CAGR of over 14% during the ...

Tunnell Consulting Forms Strategic Alliance With Ireland-Based Campbell Informatics -- Firms to provide enhanced solutions to life sciences organizations globally KING OF PRUSSIA, PA, September 15, ...

The pharmaceutical industry continues to strive to improve the quality and efficiency of clinical trials but many challenges remain with these costly and complex operations. One key factor in ...

Researchers milling around in a wide-open laboratory with lots of machines and computers. Scientists in Recursion Pharmaceuticals' automated high-throughput screening laboratory in Salt Lake City, ...

Over the past 20 years, many factors, including globalization, supplier specialization and reimbursement pressures to reduce cost, have increased the complexity of the drug-making process. Pharma 4.0 ...

The global drug discovery informatics market is poised for a transformational leap, with its valuation projected to grow from USD 16,445.1 million in 2025 to an impressive USD 64,814.3 million by 2035 ...

Constantine Kreatsoulas, PhD has joined Circle Pharma as its Vice President of Research Informatics and Computational Chemistry. Dr. Kreatsoulas joins Circle from GlaxoSmithKline (GSK) where he was ...